Inhibition of human immunodeficiency virus type 1 reverse transcriptase dimerization using synthetic peptides derived from the connection domain.
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Based on presently available information on the structure of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase, peptides have been synthesized which correspond to the sequence of a particular region of the protein involved in formation of the active heterodimeric form of the enzyme. Several peptides that are 15-19 amino acids long and that are derived from the so-called connection domain of the reverse transcriptase are able to inhibit dimerization of the enzyme and thus inhibit development of its enzymatic activities. In particular, a tryptophan-rich 19-mer corresponding to residues 389-407 was relatively efficient, showing an apparent dissociation constant in the micromolar range for one or both of the subunits. The sequence of this region is identical for both subunits, since one (molecular mass of 51 kDa) is the proteolytic product of the other (molecular mass of 66 kDa). Dissociation of the preformed heterodimer could not be induced by the peptides, but increasing concentrations reduced the rate of dimerization in a concentration-dependent manner until it became immeasurable at high concentrations. The results suggest that inhibition of dimerization of reverse transcriptase is an attractive approach to chemotherapeutic intervention in HIV infection and that further development of peptide-based inhibition strategies is worth pursuing.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor
Kohlstaedt, L. A., Wang, J., Friedman, J. M., Rice, P. A., & Steitz, T. A. (1992) · Science · doi:10.1126/science.1377403 · Cited by 1,914
Jacobo-Molina, A., Ding, J., Nanni, R. G., Clark, A. D., Lu, X., Tantillo, C., Williams, R. L., Kamer, G., Ferris, A. L., Clark, P., et al. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.13.6320 · Cited by 1,115
Research works printed but not linked: 19
- Baillon, 1991, New Biol., 3, 1015
- Baltimore, 1988, Nature, 335, 396, 10.1038/335395a0 · DOI · Paper page
- Barré-Sinoussi, 1983, Science, 220, 868, 10.1126/science.6189183 · DOI · Paper page
- Bradford, 1976, Anal. Biochem., 72, 248, 10.1016/0003-2697(76)90527-3 · DOI · Paper page
- Chandra, 1986, FEBS Lett., 200, 327, 10.1016/0014-5793(86)81162-0 · doi:10.1016/0014-5793(86)81162-0
- Cohen, 1986, Nature, 321, 441, 10.1038/321441a0 · DOI · Paper page
- De Clercq, 1992, AIDS Res. Human Retroviruses, 8, 119, 10.1089/aid.1992.8.119 · DOI · Paper page
- Di Marzo Veronese, 1986, Science, 231, 1289, 10.1126/science.2418504 · DOI · Paper page
- Divita, 1993, FEBS Lett., 324, 153, 10.1016/0014-5793(93)81383-B · DOI
- Dutia, 1986, Nature, 321, 439, 10.1038/321439a0 · DOI · Paper page
- Grob, 1992, AIDS Res. Human Retroviruses, 8, 145, 10.1089/aid.1992.8.145 · DOI
- Lightfoot, 1986, J. Virol., 60, 771, 10.1128/jvi.60.2.771-775.1986 · DOI · Paper page
- Müller, 1989, J. Biol. Chem., 264, 13975, 10.1016/S0021-9258(18)71628-1 · DOI · Paper page
- Müller, 1991, J. Biol. Chem., 266, 14709, 10.1016/S0021-9258(18)98744-2 · DOI
- Nanni, 1993, Perspect. Drug Discov. Design, 1, 129, 10.1007/BF02171659 · DOI
- Restle, 1990, J. Biol. Chem., 265, 8986, 10.1016/S0021-9258(19)38799-X · DOI · Paper page
- Restle, 1992, J. Biol. Chem., 267, 14654, 10.1016/S0021-9258(18)42091-1 · DOI
- Rey, 1987, J. Virol. Methods, 16, 239, 10.1016/0166-0934(87)90008-5 · DOI
- Zhang, 1991, J. Biol. Chem., 266, 15591, 10.1016/S0021-9258(18)98445-0 · DOI · Paper page
Cited by
Peptide and Protein Recognition by Designed Molecules
Peczuh, M. W., & Hamilton, A. D. (2000) · Chemical Reviews · doi:10.1021/cr9900026 · Cited by 545
Malik, H. S., & Eickbush, T. H. (2001) · Genome Research · doi:10.1101/gr.185101 · Cited by 248
Disruption of protein–protein interactions: Towards new targets for chemotherapy
Loregian, A., & Palù, G. (2005) · Journal of Cellular Physiology · doi:10.1002/jcp.20356 · Cited by 108
Camarasa, M.-J., Velázquez, S., San-Félix, A., Pérez-Pérez, M.-J., & Gago, F. (2006) · Antiviral Research · doi:10.1016/j.antiviral.2006.05.021 · Cited by 66
Insight into the mechanism of a peptide inhibitor of HIV reverse transcriptase dimerization
Depollier, J., Hourdou, M.-L., Aldrian-Herrada, G., Rothwell, P., Restle, T., & Divita, G. (2005) · Biochemistry · doi:10.1021/bi0484264 · Cited by 28
Self-citation
Metadata
- Authors
- Divita, G., Restle, T., Goody, R. S., Chermann, J. C., & Baillon, J. G.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1994-05
- Volume
- 269
- Issue
- 18
- Pages
- 13080-13083
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1507986200
- Cited by
- 78
- References
- 2
- FWCI
- 3.13
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 9674 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Inhibition of human immunodeficiency virus type 1 reverse transcriptase dimerization using synthetic peptides derived from the connection domain. https://app.cochat.ai/papers/10.1016/s0021-9258(17)36800-x
- The paper
- Divita, G., Restle, T., Goody, R. S., Chermann, J. C., & Baillon, J. G. (1994). Inhibition of human immunodeficiency virus type 1 reverse transcriptase dimerization using synthetic peptides derived from the connection domain. Journal of Biological Chemistry. https://doi.org/10.1016/s0021-9258(17)36800-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.